ELCC 2025 Satellite Symposium: Dr Thomas Newsom-Davis
Dr Thomas Newsom-Davies discusses expanding treatment options in ES-SCLC.
Watch Video
ELCC 2025 Satellite Symposium: Professor Francesco Grossi
Professor Francesco Grossi discusses emerging chemo-immunotherapy data in first-line in ES-SCLC.
Watch Video
ELCC 2025 Satellite Symposium: Professor Martin Reck
Professor Martin Reck discusses how to navigate second-line treatment of ES-SCLC
Watch Video
ELCC 2025: Prof. Francesco Grossi – ASTRUM-005 Study Design
Professor Francesco Grossi discusses the ASTRUM-005 during the promotional symposium sponsored by Accord Healthcare Ltd at ELCC 2025
Watch Video
ELCC 2025: Dr Thomas Newsom-Davis – SCLC Treatment Options
Dr Thomas Newsom-Davies discusses small-cell lung cancer treatment options during the promotional symposium sponsored by Accord Healthcare Ltd at ELCC 2025
Watch Video
ELCC 2025: Prof. Francesco Grossi – Serplulimab Meta-analysis Benefit
Professor Francesco Grossi discusses serplulimab meta-analysis benefits during the promotional symposium sponsored by Accord Healthcare Ltd at ELCC 2025
Watch Video
Serplulimab Mechanism of Action – Prof. Francesco Grossi
Professor Francesco Grossi discusses the mechanism of action for serplulimab during the promotional symposium sponsored by Accord Healthcare Ltd at ELCC 2025
Watch VideoELCC 2025, European Lung Cancer Congress 2025; ES-SCLC, extensive-stage small-cell lung cancer
If you would like to meet with your local Accord representative, please click here.